drugset / Trial / NCT00003755
Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor
Phase 1
Completed
40 enrolled
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of Ro 31-7453 in treating patients who have locally advanced or metastatic solid tumor.
Timeline
- Start
- 1998-10
- Primary completion
- 2001-08
- Completion
- 2001-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MKC-1 | Small molecule | — | Oral |